Pharma Cos. Slam Cert. Bid In Diabetes Drug Price-Fixing Suit

By Julia Arciga · May 28, 2020, 8:53 PM EDT

A group of pharmaceutical companies, including Bausch Health Co., has urged a California federal judge not to certify a class of buyers claiming the companies violated federal antitrust law by blocking...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re Glumetza Antitrust Litigation

Case Number

3:19-cv-05822

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

September 18, 2019